A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterialsbroad
WOUNDSENS · Horizon Europe grant · 2023-11-01–2027-10-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2022-PATHFINDERCHALLENGES-01-04. CORDIS record →
Objective
Global healthcare associated with chronic non-healing wounds can be considered a main public health problem as affects up to 2% of the world population. A novel approach is needed mainly to support the quality of life of the people suffering from this silent epidemic and additionally, alleviate the impact in costs and resources for the healthcare system. Up to date, no smart bandages have made it to the real market and research state is still going on for a reliable and sensitive inspection method. The main goal of WOUNDSENS project is to lead the development of a novel generation of wearable biosensors with a synergy of technological breakthroughs in transversal fields of knowledge. Sensor elements, for the first time, will directly become a compatible part of the wound dressing material itself resulting in enhanced wearing comfort and operability. Accordingly, they will be integratable into manufacturers' existing standard processes (suturing, embroidery, roll-to-roll). Our proposal presents a parading shift in smart wound dressings constructed on novel hollow fibers with radial bio-signaling based on engineered novel enzymes. WOUNDSENS presents a leading-edge new technology with the design and development of innovative electrochemical materials with step forward advances in CONDUCTIVE MATERIAL, the development of electrospun neofibers and processes with leading edge methodologies on ELECTROSPINNING and the ENZYME ENGINEERING of a new family of detection biocatalysts (resurrected and extant enzymes) to secure a sensitive and reliable signal. WOUNDSENS proposal accepts the challenge of pushing forward the new technological platform to design a new concept in continuous wound control and monitoring improving the life of millions of people.
Beneficiaries (4)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| EVOENZYME SL | ES | coordinator | €1,269,300 | Yes |
| NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN | DE | participant | €1,074,749 | |
| UNIVERSITE DE LORRAINE | FR | participant | €590,270 | |
| CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS | FR | thirdParty | €0 |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.